Iron Chelation Therapy in Myelodysplastic Syndromes: Where Do We Stand?

Expert Review of Hematology- United Kingdom

doi 10.1586/17474086.2013.814456

Full Text

Abstract

Available in

Categories

Hematology

Date

Authors

Publisher

Informa UK Limited

Related search

Blockchain in Academia: Where Do We Stand and Where Do We Go?

2020English

Schistosomiasis Vaccines: Where Do We Stand?

Parasites and Vectors
ParasitologyInfectious Diseases
2016English

High Energy Neutrino Astronomy: Where Do We Stand, Where Do We Go?

Physics of Particles and Nuclei
High Energy PhysicsNuclear
2018English

Where Do We Stand After Coty?

Competition Law Journal
2018English

Quantum Computers: Where Do We Stand?

Europhysics News
AstronomyPhysics
2005English

Iron Overload in Myelodysplastic Syndromes

Expert Review of Hematology
Hematology
2009English

Stem Cell Therapy for Lower Extremity Diabetic Ulcers: Where Do We Stand?

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2013English

Transplantation Tolerance: The Big Picture. Where Do We Stand, Where Should We Go?

Clinical and Experimental Immunology
AllergyImmunology
2017English

Simulation in Cardiothoracic Surgical Training: Where Do We Stand?

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy